Latest News

A team led by John Tsang, PhD, MMath, Anthony N. Brady Professor of Immunobiology, has been awarded a £4,200,000 grant from the Advanced Research + Invention Agency (ARIA) for a project that aims to decode and engineer coordinated immune responses that rapidly clear viruses in an effort to minimize viral spread and immunopathology.

A Q&A with Alexandra Bayer Wildberger, PhD, a postdoctoral associate in the lab of Kevin O’Connor, PhD, who was selected to receive a 2026 American Brain Foundation Next Generation Research Grant in the area of myasthenia gravis for her project, “Investigating the Role of the Immune System’s First Responders in Myasthenia Gravis.”

Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab—recently approved for pediatric patients with Stage III type 1 diabetes—delays the progression of the disease.

Degradation of the immune system’s critical maintenance work could be a target for extending a healthy lifespan.

Gut-homing antibodies provide powerful protection against norovirus, a new Yale study finds, revealing a potential new path for developing vaccines and therapies.

In today’s health headlines, what to know about genital herpes – how common is it and why there is a stigma around it, a new vaccine to prevent herpes is in the works, and how the specialized approach for this vaccine might lead the way against other viruses. Dr. Akiko Iwasaki, Sterling Professor of immunobiology at Yale University School of Medicine, joined Good Morning Connecticut at 9 a.m. to discuss.

Immunologist Arya Ökten gives a TEDxYale talk

Founded at a pivotal moment in national research policy, Women’s Health Research at Yale helped close critical knowledge gaps in medicine—and is now advancing a new era of biologically-informed care that improves treatment for women and men.

Yale School of Medicine received a $2.5 million gift from the Colton Foundation to advance the work of the Colton Center for Autoimmunity at Yale and the Colton Consortium for Autoimmunity. The consortium is a global partnership among the four Colton Centers at Yale, the University of Pennsylvania (Penn), New York University (NYU), and Tel Aviv University (TAU).